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Abstract. It has been suggested that systemic infection, occurring during aging and chronic neurodegenerative diseases, can
evoke an immune response that aggravates the progression of neurodegeneration and cognitive decline. It has been shown that
the AD11 neurodegeneration mouse model, expressing a recombinant anti-nerve growth factor (NGF) antibody, shows a milder
phenotype when housed in murine pathogen-free (MPF) conditions with respect to AD11 mice reared in conventional (CV)
housing. AD10 mice, a variant of the anti-NGF AD11 model, expressing only an immunoglobulin light chain for the transgenic
anti-NGF antibody, in the absence of the corresponding transgenic antibody chain VH, exhibit a complex neurodegenerative
phenotype, similar to that of AD11 mice. Here we show that the AD10 transgenic mice, housed in murine pathogen-free conditions
(MPF-AD10 mice), also display a milder behavioral and neurodegenerative phenotype compared to the corresponding mice kept
under conventional housing conditions (CV-AD10). As a first step toward the identification of mechanisms underlying this
difference, a differential gene expression profiling was performed on brains from CV-AD10 and MPF-AD10 mice, showing a
decrease of the immune response and neuroinflammation gene expression in MPF-AD10 mice. Results suggest that the activation
of the immune response gene expression in the CV-AD10, in a microbially unprotected environment, might contribute to a more
severe and progressive neurodegenerative phenotype, compared to the MPF mice.
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INTRODUCTION
Molecular cross-talk between the immune and ner-
vous systems may contribute to the pathogenesis and
progression of both neurodevelopmental and neu-
rodegenerative disorders. Several studies suggest that
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systemic infection, occurring during aging and chronic
neurodegenerative diseases, can evoke an exaggerated
immune response that contributes to the progression
of neurodegeneration and cognitive decline [1]. The
anti-NGF AD11 mouse model develops a progressive
neurodegeneration as consequence of selective neu-
tralization of mature nerve growth factor (NGF) with
respect to its unprocessed precursor [2–4]. It has been
shown that raising AD11 anti-NGF transgenic mice in a
murine pathogen-free (MPF) condition slows the onset
of neurodegeneration that they develop when raised
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in conventional housing (CV-AD11) [5]. Moreover,
in the AD11 neurodegeneration model, downstream
effectors of activated immune response and inflamma-
tory pathways were also found to be regulated as one
of the earliest events in the progression of neurode-
generation in CV-AD11 mice [6]. On the whole, these
data revealed a complex picture of an immunotrophic
and inflammatory imbalance in brain regions of AD11
mice that might have a significant role in the neurode-
generative process.
A neurodegenerative phenotype akin to that of AD11
mice develops in AD10 mice which only express
the VK light chain of anti-NGF antibody [7]. In the
absence of a corresponding heavy chain (VH) trans-
gene, the VK light chain forms a hybrid antibody with
endogenous mouse IgG heavy chain in lymphocytes.
The production of AD10 mice takes advantage from the
generation of hybrid antibodies, made from the assem-
bly of rearranged transgenic light chains, expressed
in lymphocytes, with endogenous heavy chains, from
the repertoire of the host mouse. Hybrid antibodies
have been well described in the context of immunolog-
ical studies on Ig locus rearrangements, transcription,
allelic exclusion, and production of transgenic mice
[8].
In our context, AD10 mice express a functional
hybrid anti-NGF antibody derived by the assembly
of the exogenous anti-NGF transgenic antibody light
chain (VK), with any of a number of endogenous
heavy chains expressed in the host mouse lympho-
cytes. Since anti-NGF hybrid antibodies are formed
in the absence of the corresponding transgenic anti-
NGF antibody heavy chain (VH), they are obligatorily
formed in the lymphocytes of the mouse and there-
fore are primarily expressed systemically [7]. Quite
unexpectedly, it was found that AD10 mice exhibit a
complex neurodegenerative phenotype, similar to that
of anti-NGF AD11 mice [7]. AD10 mice develop a
central neurodegeneration characterized by choliner-
gic deficit, tau hyperphosphorylation, amyloid- (A)
accumulation derived from the altered processing of
endogenous mouse APP, and by deficits in non-
spatial and spatial memory [7]. This demonstrated that
the central neurodegeneration observed in AD10 mice
has a peripheral, systemic origin [7], deriving from the
circulating hybrid mouse-human anti-NGF antibodies
[7]. In this study, we investigated whether AD10 mice,
similarly to AD11 mice, when housed in pathogen-
free conditions (MPF-AD10) would also show a milder
neurodegeneration phenotype. We were guided by the
hypothesis that since an endogenous immune system is
necessary to form hybrid anti-NGF antibodies, in the
form of a repertoire of heavy chains, some of which
should be permissive to reconstitute a functional anti-
NGF antibody, when assembled with the transgenic
anti-NGF light chain, the likelihood to form hybrid
anti-NGF antibodies would be lower under MPF con-
ditions, in comparison to CV conditions.
MATERIALS AND METHODS
Anti-NGF AD10 mouse model
AD10 mice [2] were obtained by pronuclear injec-
tion of the plasmid pcDNA-neo/VKD11 HuCK into
zygotes of C57BL/6xSJLF2 hybrid mice [9]. This plas-
mid harbors the variable regions from the rat D11
anti-NGF antibody linked to a human Ck constant
region (to facilitate the detection of transgenic anti-
bodies against the background of mouse Igs), under the
transcriptional control of the human cytomegalovirus
(CMV) early region promoter. Analysis of transgenic
mice was performed by PCR on genomic DNA from
tail biopsies, as described [7]. For the analysis of a sep-
arate cohort in MPF housing conditions, AD10 mice
were re-derived at Taconic and crossed to C57BL/6
females at EPFL. Heterozygous male offspring and
wild-type (WT) littermates were analyzed in gener-
ations F2-F4.
Housing conditions
Mice were kept in plastic cages under a 12 hours
dark to light cycle (lights on at 7.30 am), constant room
temperature (22 ± 2◦C) with food and water ad libi-
tum at the conventional facility in the European Brain
Research Institute (EBRI, Rome, Italy).
For MPF conditions, we used the animal facility at
EPFL, Lausanne, using the same housing conditions
as for the CV-housed mice.
Experiments were performed according to the
national and international laws for laboratory animal
welfare and experimentation (EEC council directive
86/609, OJ L 358, 12 December 1987). All proce-
dures performed at EPFL also complied with the
Swiss National Institutional Guidelines on Animal
Experimentation and approved by the Swiss Cantonal
Veterinary Office Committee for Animal Experimen-
tation.
Morris water maze
The water maze apparatus consisted of a circular
pool (140 cm diameter) that was filled with opaque
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water. The temperature was maintained at 26ºC±1ºC
during the experiment. A 10 × 10 cm² platform was
placed 1.3 cm below the water surface. The water maze
was surrounded by clearly discernible visual cues to
facilitate spatial orientation during the training phase.
The experiment was divided in three phases. The habit-
uation phase consisted of 2 × 1-minute trials during
which mice were habituated to the room and appara-
tus (with the platform in the center of the pool). The
pool was surrounded by curtains so that there were no
visual cues available for orientation. After one day, the
training phase started. Spatial learning sessions were
conducted for three consecutive days and each animal
was subjected to 4 × 60-second trials/day with an inter-
val of 15–20 minutes between two consecutive trials.
The platform remained constantly at a target quadrant.
The starting point for each trial was randomly chosen.
In order to assess the spatial memory of the animals, a
probe trial was performed 24 hours after the last train-
ing session (day 4). During this phase, the platform was
removed and the mice were allowed to swim freely for
60 seconds. The data were analyzed in blocks of two
trials (B1 to B6), and the distance that the animals
swam to find the platform was used as an indication of
learning. The percentage of the time spent in the quad-
rant that contained the platform during training (target
quadrant) versus the opposite quadrant was used as an
index of spatial memory.
Data collection and statistical analysis
In the water maze, mice were tracked automati-
cally with EthoVision 3.0/3.1 (Noldus, Wageningen,
the Netherlands). The results were analyzed using the
SPSS 13.0 statistical package and the graphs were
made using GraphPad Prism 5.
The data were analyzed with analysis of variance
(ANOVA) with repeated measures, Student’s t-tests,
and one-sample t-tests as considered appropriate. All
results represent the mean ± the standard error of the
mean (SEM) and the significance was set at p≤ 0.05.
Anti-NGF antibody detection in blood serum and
brain
The serum and brains of AD10 mice were tested for
the presence of hybrid anti-NGF antibodies composed
from the assembly of transgenic rat/human D11 light
chain to mouse heavy chains. Hybrid anti-NGF anti-
bodies were quantified using biotinylated anti-human
K chain antibodies. Blood sera from 3 month-old WT
(n = 8), CV-AD10 mice (n = 8), and MPF-AD10 mice
(n = 13) were diluted 1 : 10 in 2% milk/PBS and used
for ELISA in plates coated with 5g/ml of mouse
NGF. The amounts of recombinant antibody found in
the serum and in the brain were determined by com-
parison to a calibration curve. Purified D11 antibody
dilutions were prepared, in the range between 0.125
and 250 ng of purified D11, in 2% milk/PBS contain-
ing 1 : 10 dilutions of blood serum or brain extracts
from control mice, as appropriate.
Immunohistochemistry and histological analysis
Mice were anesthetized with pentobarbital to
150 mg/kg and perfused with 50 ml 4% PFA in PBS.
Brains were removed and post-fixed overnight in the
same fixative, cryoprotected in 30% sucrose, and
embedded for cryostat. Coronal sections (30m) were
washed with 25 mM Tris-buffered saline pH 7.4 con-
taining 0.3% Triton X-100, quenched with 3% H2O2,
blocked with 1% BSA and labeled at 4◦C as described
using goat anti-ChAT antibody (EMD Millipore, Bil-
lerica, CA), mouse anti-4G8 (Covance, Princeton,
NJ) 1 : 250, or goat anti-NH2 beta (N-18) 1 : 100
from Santa Cruz (Santa Cruz Biotechnology, Santa
Cruz, CA) against amyloid A4 at 1 : 900 and 1 : 100
dilutions, respectively. Secondary antibodies were
biotinylated rabbit anti-goat IgG 1 : 400 and 1 : 100,
respectively (Vector Laboratories Inc., Burlingame,
CA). Signal was amplified with Vectastain Elite ABC
kit (Vector labs) followed by DAB-glucose oxidase
(Sigma-Aldrich, St. Louis, MO) detection for ChAT,
and Vectastain ABC-AP kit followed by alkaline phos-
phatase staining for amyloid. Images were acquired
using a wide field Olympus AX70 microscope.
Images for the quantification of ChAT positive cells
were obtained using the Olympus Virtual Slide Scanner
VS120-SL using a 20x objective. The area correspond-
ing to the medial septum (anatomical coordinates from
Paxinos & Franklin’s Mouse Brain Atlas, [10]) was
designed and specified manually and then cell counting
was performed using a custom-made macro running
in Fiji [11]. Cells were quantified dorsally to a line
passing through the anterior commissure, which thus
served as an anatomical boundary for the region of
interest. For each animal (n = 5 for MPF-AD10; n = 5
for MPF-WT, and n = 6 for CV-AD10 mice), four sec-
tions of the medial septum were quantified ranging
from 0.85 to 0.37 mm from Bregma and were matched
anteroposteriorly. Additionally, the selected area was
automatically measured for each section. Through this
procedure, a standardized measurement was obtained
by calculating the number of counted cells/mm2 for
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each section, thus representing the average cell den-
sity in the medial septum for each animal. The number
of A clusters was determined as described [7].
ELISA
To quantify the amount of insoluble A1–42, brains
from CV-AD10 (n = 6), MPF-WT (n = 4), and MPF-
AD10 (n = 4) mice were removed and homogenized
as described before [12, 13]. A sandwich ELISA was
performed [14, 15]. The monoclonal antibody mAb
4G8 was used as capturing antibody while the rab-
bit polyclonal antibody against A1-42 (Life Science
Technologies Ltd, Paisley, UK) was used as detecting
antibody. Brains from WT mice were processed in par-
allel with the transgenic tissue. The sensitivity of the
ELISA was 10 pmol/ml.
RNA isolation and Real-Time qRT-PCR
Hippocampal regions from 3 AD10 mice housed
in MPF and of 3 age-matched AD10 mice in con-
ventional housing were dissected from the right brain
hemispheres at 1 or 3 months of age and stored in
RNAlater (QIAGEN, Hilden, Germany). Total RNA
was isolated using Trizol (Life Technologies, Grand
Island, NY) and DNAse, by Qiagen columns. RNA
concentrations were determined on a NanoDrop UV-
VIS. Only samples with an absorbance ratio in the
range 1.8 < OD260/OD280 < 2.0 were selected. Qual-
ity of RNA samples was checked for integrity with the
Agilent BioAnalyzer 2100 (Agilent RNA 6000 nano
kit, Agilent Technologies, Santa Clara, CA): samples
with a RIN index below 8.0 were discarded.
For qRT-PCR, each RNA sample was subjected
to reverse transcriptase and Real-Time PCR. The
mRNA for the VK antibody chains was also deter-
mined in each mouse by qRT-PCR with the following
primers, specific for the D11 variable region anti-
body chains: VKs AGCAGAAGCCAGGGAAATCT,
VKas TACCTTGCATACTGGGGTCC. The mRNAs
for CD74 and Ccl6 were determined in each mouse
with the following primers: CD74 s CTCCCTGGAG-
GAGAAGAAGC; CD74as TTACCGTTCTCGTCG-
CACTT; Ccl6 s TCTTTATCCTTGTGGCTGTCC;
Ccl6as TGGAGGGTTATAGCGACGAT.
Microarray analysis
The gene expression profiling was performed
using the One-Color Microarray Agilent Platform
(Agilent Technologies, Santa Clara, CA) according
to the standard Agilent protocol. Agilent 8x60K
whole mouse genome oligonucleotide microarray
chips were used (p/n G4852A). Post-hybridization
image acquisition was accomplished using the Agi-
lent Scanner G2564B. Data extraction from the 20 bits
TIFF images was accomplished by Agilent Feature
Extraction version 10.1 software using the standard
Agilent one-color gene expression extraction proto-
col (GE1 107 Sep09). Data filtering and analysis were
performed using Agilent GeneSpring GX ver11.0 soft-
ware and Microsoft Excel (Microsoft Corp., Redmond,
WA). The “gProcessedSignal” data column of the Fea-
ture Extraction *.txt output files was used, containing
the median signals corrected by spatial and multi-
plicative detrend. Data quality filtering was performed
discarding features with the Feature Extraction flag
gIsWellAboveBG = 0 in any of the samples. Log2 fil-
tered data were normalized to the 75th percentile.
Functional annotations of differential gene lists were
performed using the DAVID tool.
RESULTS
Hybrid anti-NGF antibodies are undetectable in
MPF-AD10
AD10 transgenic mice, which express only the
transgenic light K chain from the anti-NGF anti-
body, are characterized by the assembly of the
anti-NGF transgenic human light chains with endoge-
nous mouse immunoglobulin heavy chains, yielding
hybrid anti-NGF immunoglobulins secreted from
mouse lymphocytes [7]. In AD10 mice, peripheral
NGF neutralization elicits shrinkage of superior cer-
vical ganglia (immunosympathectomy) and, as a
consequence of this, peripheral anti-NGF antibodies
cross the blood-brain barrier and reach the brain, gen-
erating an anti-NGF-dependent neurodegeneration,
largely superimposable to that observed in AD11 mice
(reviewed in [16]).
The presence or absence of hybrid anti-NGF anti-
bodies, formed by endogenous heavy chain of IgG
with the transgenic light chain of the D11 recombi-
nant antibody was verified by ELISA on the sera of the
AD10 mice housed in MPF and CV conditions, respec-
tively (Fig. 1A). As expected, the CV mice express
the recombinant hybrid anti-NGF antibodies while,
surprisingly, the MPF-AD10 mice do not express the
hybrid antibody (Fig. 1B), notwithstanding the fact
that they express the transgenic anti-NGF light chain
[7].
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Fig. 1. The presence of hybrid antibodies obtained from the assembly of an endogenous heavy chain of IgG with the transgenic light chain of
the D11 recombinant antibody was verified by ELISA on the sera of the AD10 mice and showed that CV-AD10 mice express hybrid anti-NGF
antibodies, while MPF-AD10 mice do not express appreciable levels of hybrid anti-NGF antibodies.
This demonstrates that the activation state of the
immune system has a direct consequence on the levels
of hybrid anti-NGF antibodies in AD10 mice.
MPF-AD10 mice are not impaired in their spatial
learning and memory
CV-AD10 mice show a progressive impairment in
spatial learning and memory, as assessed by the Mor-
ris water maze test [17]. By contrast, MPF mice
learned the position of the hidden platform at 6 months
(Fig. 2A; F4,166 = 11.280, p < 0.001) and 9 months
of age (Fig. 2B; F5,75 = 6.173, p < 0.001). Indeed,
no effect of genotype was found at either 6 months
(F1,42 = 0.001, p = 0.980) or 9 months (F1,15 = 0.403,
p = 0.535) of age. In the probe trial, both groups
spent significantly more time swimming in the tar-
get quadrant, compared to the chance level (25%),
indicating that the spatial memory of MPF-AD10 is
intact when tested at 6 months of age (Fig. 2 C; MPF-;
WT: t20 = 2.258, p = 0.035, MPF-AD10: t22 = 5.624,
p < 0.001, one-sample t-test) and 9 months of age
(Fig. 2D; MPF-WT: t7 = 2.636,p = 0.034, MPF-AD10:
t8 = 4.384, p = 0.002, one-sample t-test). These results
support the fact that the spatial memory of the AD10
animals reared under MPF conditions remains intact,
even at the age of 9 months.
MPF-AD10 mice do not develop an overt
neurodegeneration
In AD11 mice reared in MPF conditions, neu-
rodegeneration is dramatically reduced [5]. Thus, we
investigated whether MPF conditions also reduce the
neurodegeneration phenotype in AD10 mice. Label-
ing of hippocampal coronal sections with anti-A
antibody, at the age of 12–14 months, revealed a
robust staining of amyloid plaques in 12–14 month-
old CV-AD10 brains (n = 3), but not in age-matched
MPF-AD10 (n = 5) (Fig. 3A-D). The absence of A
deposition was confirmed by ELISA performed on
insoluble fractions of brain extracts (Fig. 3E).
In 6-months old CV-AD10 mice, the number
of choline acetyltransferase (ChAT)-immunoreactive
neurons is decreased compared to the CV-WT in num-
bers, by a reduction of about 40–50% ([7] and Fig. 4C).
On the contrary, the number of ChAT immunoreactive
neurons appeared to be normal in MPF-AD10 mice
at all ages examined between 6–12 months (Fig. 4A-
C; n = 6/6, and data not shown). Quantification of the
ChAT positive cells revealed that there is no signif-
icant difference between MPF-WT and MPF-AD10
(Fig. 4C: t8 = 1.437, p = 0.189, t-test). These results
indicate that the neurodegeneration in MPF-AD10
is less pronounced, if not absent, compared to stan-
dard housing conditions. This is in line with the fact
that MPF-AD10 show negligible levels of circulating
hybrid anti-NGF antibodies (Fig. 1).
Global microarray differential data expression in
CV-AD10 mice versus MPF-AD10 mice
To gain insight into the early events induced by
anti-NGF antibodies expression in AD10 mice, under
MPF and CV housing conditions, we performed a gene
expression microarray analysis in the hippocampus of
CV- and MPF-AD10 mice at 1 and 3 months of age.
Data show that many genes are differentially
expressed in the CV-AD10 compared to MPF-AD10
mice. Figure 5 presents data on the overall statistics of
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Fig. 2. Spatial learning and memory in the Morris water maze. No difference was observed between the genotypes in the acquisition phase
of the water maze whether trained at 6 (A) or at 9 (B) months of age. Similarly, no differences between the two genotypes were found in the
respective probe tests (C and D), with both groups exhibiting good memory as indicated by their time spent in the target quadrant. Results are
the mean ± SEM (6 months, N: WT = 21, MPF-AD10 = 23; 9 months, N: WT = 8, MPF-AD10 = 9) +p < 0.05 one-sample t-test against chance
level.
the mRNAs that are differentially expressed (green for
the down-regulated and red for the upregulated) in the
hippocampus from CV-AD10 mice, versus the MPF-
AD10 mice, at 1 and 3 months of age. Data show that
the total number of differentially expressed mRNAs,
in CV-AD10 versus MPF-AD10 mice, is higher at 1
month, compared to the 3 months of age, suggesting
a very early involvement of the hippocampus in the
AD10 neurodegeneration pathogenesis of CV-AD10
mice.
Differentially expressed genes in the hippocampus
of CV-AD10 mice versus MPF-AD10 mice
The functional analysis (Gene Ontology) of the sta-
tistically significant down-regulated and upregulated
genes of the CV-AD10/MPF-AD10 at 1 and 3 months
of age is reported in Figs. 6 and 7, respectively. In the
expression profile of 1 month of age, the CV-AD10
group shows a striking down-regulation of gene fam-
ilies related to chromatin organization and epigenetic
regulation of gene expression, alongside an upregu-
lation of gene families related to neurogenesis and
neuronal development and differentiation (Fig. 6A, B).
The functional analysis of the down-regulated and
upregulated genes at 3 months of age (Fig. 7A, B)
shows a main regulation of the immune response genes
among the selected families, with an upregulation of
the major histocompatibility complex genes and other
immune related genes in the CV-AD10 mice with
respect to MPF-AD10 mice. The overall distribution
of upregulated and down-regulated genes related to
inflammatory response, as reported in Fig. 8, shows
that, at 3 months, the majority (59% of genes) of this
functional category in the CV-AD10 mice is upregu-
lated compared to the MPF-AD10 mice: there is a shift
in this expression profile with age, since at 1 month the
proportion of up- and down-regulated genes is very
different. Comparing the number of up- and down-
regulated genes at the two ages in a contingency table
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Fig. 3. Comparison of A neurodegeneration in AD10 mice reared in MPF or CV housing. Anti-A staining of (A) WT and (B) MPF-AD10
versus (C) CV-AD10 in coronal sections of the hippocampus at 12–14 months of age. (D) Quantification of A clusters in hippocampal sections.
(E) ELISA for A1–42 formic acid extracts from WT, CV-AD10, and MPF-AD10 brains. Bars are representative of mean ± SEM. Size bars:
500m.
by Fisher test shows ap-value <10−3. The genes related
to the “inflammatory response” are more upregulated
(59%) than down-regulated ones (41%) at 3 months
of age, while at 1 month 44% of this gene family are
upregulated versus 56% down-regulated (Fig. 8A, B).
We defined “inflammation related” genes, the genes
with the “inflammatory response” annotation in the
Gene Ontology database (Supplementary Table 1).
These data show that the MPF condition changes
the overall balance of the inflammatory genes and low-
ers the expression level of inflammation and immune
related genes, thus determining a reduced neuroinflam-
matory phenotype. The list of the immune response
Table 1
Validation of microarray data by qRT-PCR in the hippocampus of
CV and MPF-AD10 mice
qRT PCR microarray
CD74 0.89 0.82
Ccl6 0.89 0.8
Values correspond to the Log2 ratio CV-AD10/MPF-AD10.
pathway genes differentially expressed at 3 months of
age is shown in Supplementary Table 2, and mainly
involves the upregulation of genes of the MHC com-
plex, the classical complement activation pathway
and some cytokines, while collagen alpha, heme,
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A
B
C
Fig. 4. Absence of cholinergic deficit in MPF-AD10 mice. Anti-
ChAT immunostaining in the medial septum of (A) MPF-WT and
(B) MPF-AD10 mice at the age of 6 months. (C) No significant differ-
ence in the number of ChAT-positive cells in the medial septum was
observed between MPF-WT and MPF-AD10 at the age of 6 months,
while in CV-AD10 mice a 40% decrease in the number of ChAT-
immunoreactive neurons can be observed. Bars are representative of
mean ± SEM. Size bars: 500m.
cytochrome families and other functional categories
are down-regulated as reported in Fig. 7A, B. We ver-
ified the expression of genes that might be related
to cognitive deficits induced by NGF-deprivation and
found a robust down-regulation of the ChAT gene in the
CV-AD10 compared to MPF-AD10 (0.4 linear scale
Fig. 5. Overall statistics of differentially expressed mRNAs. Upreg-
ulated (red) and down-regulated (green) mRNAs in hippocampus,
at 1 and 3 months of age, of CV-AD10 versus MPF-AD10 mice.
mRNAs were selected by significance analysis of microarray (SAM,
q-value <0.05) with a fc threshold of 2.0 in linear scale.
fold). This is in line with data at the immunohisto-
chemistry level (Fig. 3 and 4) and with the fact that the
decreased levels of anti-NGF antibody in the MPF-
AD10 determine milder cholinergic and behavioral
deficits than in CV-AD10 mice.
For validation, we selected two differentially
expressed genes at 3 months of age: the chemokine
Ccl6 and the antigen CD74, both involved in immune
system activation [18–19]. The results confirmed our
previous microarray data, showing an upregulation of
CD74 and of Ccl6 (Table 1). Thus, we conclude that
a milder immune response is observed in MPF-AD10
mice compared to age-matched CV-AD10 mice.
DISCUSSION
In a previous article, we showed that rearing AD11
anti-NGF mice in MPF conditions slows down the pro-
gression of the neurodegeneration [5]. In this study
we used another related transgenic anti-NGF mouse
model, the AD10 mouse, to investigate the effects
of MPF conditions on neurodegeneration and on the
production of peripheral hybrid anti-NGF antibodies.
We show that the expression of the hybrid anti-NGF
antibody is absent in MPF-AD10 mice, despite the
continuous expression of the VK light chain trans-
gene. This is likely due to a reduced activation of
the immune system under MPF conditions, leading
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Fig. 6. Functional analysis of up- or down-regulated genes in 1-month old CV-AD10 versus MPF-AD10 mice. The genes subjected to gene
ontology analysis using the cluster tool of DAVID database were upregulated >1.5-fold (A) or down-regulated <1/1.5 (B) in linear scale. For
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Immune response.
p=1.93E-03
EGF-like calcium-binding;
p=1.83E-03
Claudin;
p=3.09E-02
Heme; p=1.92E-04
Glial cell
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p=1.07E-03
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complex antigen; 
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Lymphocyte mediated
immunity; p=2.71E-03
Serine protease inhibitor;
p=2.01E-04
Processing of peptide
antigen via M HC-1;
p=2.41E-06
Domain: lg-like
C1-type;
p=1.92E-06
MHC class I protein
complex; p=6.36E-08
A B
Fig. 7. Functional analysis of up- or down-regulated genes in 3-month old CV-AD10 versus MPF-AD10 mice. The genes subjected to gene
ontology analysis using the cluster tool of DAVID database were upregulated >1.5-fold (A) or down-regulated <1/1.5 (B) in linear scale. For
each cluster a representative functional term and the corresponding p-value are shown; p-value threshold is set to 0.05. The area of each slice is
proportional to [-log2(p)]1.5.
to reduced diversity of the heavy chain repertoire and
hence a lower capability of assembling functional anti-
NGF antibodies from the anti-NGF VK chain with
endogenous VH chains. In AD10 the hybrid anti-NGF
antibodies are a “hybrid” polyclonal mixture [7], made
by one single light chain (the anti-NGF derived VK
transgenic chain), combined in mouse lymphocytes
with a mouse heavy chain, out of the whole reper-
toire of mouse heavy chains expressed by the mouse
lymphocytes. Thus, in the MPF situation, the reper-
toire of mouse heavy chains out of which heavy chains
permissive for reconstituting an anti-NGF specificity
are selected, is more limited, and therefore the overall
anti-NGF population is lower, due to the lower level of
immune system activation. Since AD10 mice housed
in MPF conditions express reduced amounts of hybrid
anti-NGF antibodies, they are “protected”, compared
to the mice housed in the conventional one (Fig. 9).
This prospects the AD10 as a model in which the over-
all circulating levels of functional anti-NGF antibodies
is directly linked to, and regulated by, the activation
levels of the immune system (Fig. 9).
There is experimental evidence that influenza and
other nasal viruses can trigger an extensive but
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Fig. 8. Overall distribution of Log2 fold change ratios of genes related to inflammatory response in CV-AD10 versus MPF-AD10 mice. Every
thin blue column along the x-axis corresponds to a gene. The gene list shown here was obtained from the AmiGO database by selecting all the
gene symbols with the “inflammatory response” term (GO:0006954) annotation, at 1 month (A) and 3 months of age (B).
covert neuroinflammation [20]. The viruses invade
the olfactory bulb through the olfactory nerves
and then associate with glial cells that release
cytokines. Epidemiological studies have associated
human neurodegeneration to viral infections by com-
mon pathogens such as herpes virus, C. pneumonia,
and influenza (reviewed in [20]). In a large cohort
study, hippocampal volume was correlated to the level
of classical inflammation biomarkers in non-demented
subjects [21]. Accordingly, damage originated by
numerous minor viral infections (such as influenza)
with both gliotropic and neurotropic viruses over a
lifetime could contribute to neurodegeneration via
cumulative neuroinflammative damage [22]. This idea
is further supported by a model where a systemic
immune challenge even during late-gestation predis-
poses WT mouse offspring to pathological brain aging,
cognitive decline, and amyloid and phosphorylated
tau neuropathology. Furthermore the same immune
challenge in adulthood is a potent driver accelerating
neurodegenerative phenotype in genetically (3xTg-
AD) predisposed animals [23]. In a previous study
we have explored the contribution of the microbial
environment to the progression of neurodegeneration
in AD11 mice [5], well aware of the fact that, in
these mice, an inflammatory immune response is one
of the earliest event in the neurodegenerative process
[6]. Here we add further information, first by show-
ing that a pathogen-free environment also alleviates
the neurodegeneration in the related AD10 model,
and secondly by analyzing gene expression in the
brain of CV-AD10 mice compared to MPF-AD10
mice. Even though CV-AD10 animals are infected
by the pathogens Norovirus, Helicobacter spp, and
Trichomonas muris that are common in conventional
husbandry, they show no apparent clinical signs of
infectious diseases. For example, Norovirus infection
is usually asymptomatic in WT and transgenic mice,
except in immunocompromised animals, where it can
also be lethal [24]: this suggests that Norovirus has the
potential to significantly activate the immune system.
This framework may be compatible with the hypoth-
esis of covert infections that activate the immune
system, as suggested by the overexpression of immune
related genes in CV-AD10 compared to MPF-AD10
(see Figs. 7-8). We found that the immune response and
inflammatory genes are upregulated in CV-AD10 mice
compared to MPF-AD10 mice. In particular, expres-
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Fig. 9. Hypothesis to explain the milder neurodegenerative phenotype of MPF-AD10 mice. Lymphocytes express IgG antibodies on their surface,
each cell expressing only one antigen-specific immunoglobulin type. Standard immunoglobulins, against common antigen, are depicted with the
endogenous light chain colored in light blue and the endogenous heavy chain in blue. Hybrid anti-NGF immunoglobulins have the exogenous
D11 light chain colored in red but the same type of heavy chain colored in blue. The small icosahedrons represent pathogens found in the
husbandry. CV-AD10-mice live in a conventional husbandry, where a higher concentration and a larger variety of pathogen, compared to MPF
husbandry, triggers a stronger immune response, globally resulting in a larger repertoire of expressed immunoglobulins. This larger repertoire
in CV-AD10 mice should increase the probability of an association between the exogenous D11 light chain and an endogenous heavy chain,
leading to a larger number of lymphocytes expressing a hybrid anti-NGF immunoglobulin. The combination of the higher concentration hybrid
anti-NGF IgGs and a greater antigen-induced infectious state could lead to the more severe neurodegenerative phenotype.
sion of the chemokine Ccl6 was increased. Ccl6 is
upregulated in a variety of inflammation models such
as the IL13-induced inflammation and experimental
demyelinating disorders in the CNS [25]. In line with
an upregulation of the immune response in CV housing
conditions, we found increased expression of CD74, an
integral membrane protein that acts both as a chaper-
one for MHC class II molecules as well as a receptor
for macrophage migration inhibitory factor [19]. The
expression of CD74 has recently been found to be
increased in microglia cells in AD cases compared to
age-matched controls [26].
The activation of an immune response in CV-
AD10 mice would increase the immune repertoire of
expressed antibody genes, thereby increasing the like-
lihood of finding a VH heavy chain that can reconstitute
a functional anti-NGF antibody with the transgenic VK
chain. The fact that the regulation of the immune genes
is mainly expressed only at 3 months of ages, thus only
after a relatively long exposure to the same pathogens,
suggests that a threshold of cumulative inflammatory
response may have to be reached, in order to make the
anti-NGF response a “predictive” neuropathological
agent.
Besides its effects on the assembly of the hybrid anti-
NGF antibody, how could the inflammatory immune
response influence the progression of the neurodegen-
eration and which is the relevance for human AD?
Immune mediators, such as cytokines, can modulate
synaptic transmission and alter the morphology of den-
dritic spines during inflammatory processes and are
closely linked to plastic morphophysiological changes
in neurons. It has been proposed that these immune
mediators are also implicated in learning and memory
processes. Indeed, our results show that the activa-
tion of the immune response genes in the CV-AD10
mice at 3 months of age, in a microbically unprotected
environment, contribute to a more severe progressive
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neurodegenerative phenotype with altered cognitive
performances [7, 17, 27] compared to the MPF mice.
In particular, the Major Histocompatibility Complex
(MHC) class I, well known for its role in the adap-
tive immune response [28], regulates activity related
aspects of synaptic function, during development [29,
30]. MHC I molecules are crucial for a selective
maintenance of synapses during the synaptic removal
process in neurons after lesion, and the lack of MHC I
expression may impair the ability of neurons to regen-
erate axons [31]. Another immune-related molecule,
the chemokine Ccl5/RANTES, has been recently pro-
posed to be a down-regulated biomarker in a set of
plasma proteins analyzed for classification and predic-
tion of clinical AD diagnosis [32].
Besides MHC class 1 and CCl5/RANTES, the
expression data at 3 months of age showed that a
whole spectrum of inflammatory mediators are differ-
entially regulated in CV-AD10/MPF-AD10, including
complement component 1 and 4B and other genes
involved in inflammation. The relevance of the com-
plement system in the synapse selection during the
development, or the reactivation in the neurodegener-
ation process has previously been described [33]. The
complement system is a critical element of the innate
immune system recognizing and killing, or targeting
for destruction, otherwise pathogenic organisms. Com-
pelling evidence has been reported that in Alzheimer’s
disease complement activation occurs in the brain, and
that this contributes to the development of a local
inflammatory state that is correlated with cognitive
dysfunction [34].
Furthermore, we found a differential regulation of
some interleukin and interleukin receptor genes in
the hippocampus, mainly differentially expressed at
1 month of the CV-AD10 versus the MPF-AD10.
The proinflammatory cytokine interleukin-1 is crit-
ical for normal hippocampus-dependent cognition,
whereas high levels can disrupt memory and are impli-
cated in neurodegeneration. It has been reported that
neonatal bacterial infection in rats leads to marked
hippocampus-dependent memory deficits in adulthood
[35]. These data implicate a long-term change within
the immune system that, upon activation, impacts the
neural processes underlying memory. Thus, early-life
events can significantly modulate normal learning-
dependent cytokine activity within the hippocampus,
via a specific, enduring impact on brain microglial
function.
In conclusion, substantial evidence supports sys-
temic inflammation as an epigenetic factor contributing
to cognitive decline and disease progression [1]. We
have shown that this is also true in neurodegeneration
linked to NGF deficits ([5] and this paper). We con-
clude therefore that the level of systemic activation
of the immune system can have a direct influence on
the extent and progression of neurodegeneration. With-
out detracting from this conclusion, a caveat should
be stated: since, in the AD10 model, the levels of the
neurodegeneration-causing agent (namely hybrid anti-
NGF antibodies) are under the control of the activation
state of the immune system, one could argue that the
above-mentioned link between systemic immune sys-
tem activation and the extent of neurodegeneration, in
this case, has been experimentally built-in, by the way
the AD10 model was constructed.
Here we suggest that the AD10 mouse model, in
which the overall anti-NGF levels can be modulated by
the immune system activation, might represent a good
model to study a link between the immune system and
neurotrophic factor activity in influencing the onset and
progression of neurodegeneration.
We conclude that the level of systemic activation of
the immune system can have a direct influence on the
extent and progression of neurodegeneration.
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